These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 15678890)
21. Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype. Lakos G; Kiss E; Regëczy N; Tarján P; Soltész P; Zeher M; Bodolay E; Szakony S; Sipka S; Szegedi G Clin Exp Immunol; 1999 Sep; 117(3):574-9. PubMed ID: 10469065 [TBL] [Abstract][Full Text] [Related]
22. Binding of anticardiolipin antibodies to protein C via beta2-glycoprotein I (beta2-GPI): a possible mechanism in the inhibitory effect of antiphospholipid antibodies on the protein C system. Atsumi T; Khamashta MA; Amengual O; Donohoe S; Mackie I; Ichikawa K; Koike T; Hughes GR Clin Exp Immunol; 1998 May; 112(2):325-33. PubMed ID: 9649198 [TBL] [Abstract][Full Text] [Related]
24. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222 [TBL] [Abstract][Full Text] [Related]
25. Anti-Beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients. Guerin J; Casey E; Feighery C; Jackson J Autoimmunity; 1999 Oct; 31(2):109-16. PubMed ID: 10680749 [TBL] [Abstract][Full Text] [Related]
26. [Antiphospholipid syndrome and stroke]. Kitagawa Y Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744 [TBL] [Abstract][Full Text] [Related]
27. beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome. Bas de Laat H; Derksen RH; de Groot PG Clin Immunol; 2004 Aug; 112(2):161-8. PubMed ID: 15240159 [TBL] [Abstract][Full Text] [Related]
28. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome. Robbins DL; Leung S; Miller-Blair DJ; Ziboh V J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202 [TBL] [Abstract][Full Text] [Related]
29. Heterogeneous recognition of beta 2-glycoprotein I by antibodies from antiphospholipid syndrome patients. Guerin J; Sim R; Yu BB; Ferluga J; Feighery C; Jackson J Thromb Haemost; 2000 Sep; 84(3):374-80. PubMed ID: 11019958 [TBL] [Abstract][Full Text] [Related]
30. beta 2-Glycoprotein I and anti-beta 2-glycoprotein I antibodies: where are we now? Inanç M; Radway-Bright EL; Isenberg DA Br J Rheumatol; 1997 Dec; 36(12):1247-57. PubMed ID: 9448584 [TBL] [Abstract][Full Text] [Related]
31. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism. Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132 [TBL] [Abstract][Full Text] [Related]
32. Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change. de Laat B; Derksen RH; van Lummel M; Pennings MT; de Groot PG Blood; 2006 Mar; 107(5):1916-24. PubMed ID: 16269621 [TBL] [Abstract][Full Text] [Related]
33. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168 [TBL] [Abstract][Full Text] [Related]
34. Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome. Hanly JG; Smith SA Clin Exp Immunol; 2000 Jun; 120(3):537-43. PubMed ID: 10844535 [TBL] [Abstract][Full Text] [Related]
35. Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome. Matsuura E; Kobayashi K; Koike T; Shoenfeld Y; Khamashta MA; Hughes GR Lupus; 2003; 12(7):550-4. PubMed ID: 12892397 [TBL] [Abstract][Full Text] [Related]
36. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [TBL] [Abstract][Full Text] [Related]
37. Autoreactive CD4(+) T cells to beta(2)-glycoprotein I in patients with antiphospholipid syndrome. Kuwana M Autoimmun Rev; 2003 Jun; 2(4):192-8. PubMed ID: 12848945 [TBL] [Abstract][Full Text] [Related]
38. Heterogeneous behavior of anti-beta2-glycoprotein I antibodies on various commercially available enzyme immunoassay plates coated with beta2-glycoprotein I. Tsutsumi A; Ichikawa K; Matsuura E; Sawada KI; Koike T J Rheumatol; 2000 Feb; 27(2):391-6. PubMed ID: 10685803 [TBL] [Abstract][Full Text] [Related]
39. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome. Lopez D; Kobayashi K; Merrill JT; Matsuura E; Lopez LR Clin Dev Immunol; 2003; 10(2-4):203-11. PubMed ID: 14768953 [TBL] [Abstract][Full Text] [Related]
40. Antiphospholipid, anti-beta 2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome. Cuadrado MJ; Tinahones F; Camps MT; de Ramon E; Gómez-Zumaquero JM; Mujic F; Khamashta MA; Hughes GR QJM; 1998 Sep; 91(9):619-26. PubMed ID: 10024916 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]